Joshua Schafer

Insider Reports History

Location
Rockville, MD
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Joshua Schafer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joshua Schafer:

Company Role Class Num Shares Value Price $ Report Date Ownership
ZEVRA THERAPEUTICS, INC. CCO Common Stock 62,278 $572,365 $9.19 03 Feb 2026 Direct
ZEVRA THERAPEUTICS, INC. CCO Restricted Stock Unit 35,333 $269,120 $7.92 31 Jan 2026 Direct
Shuttle Pharmaceuticals Holdings, Inc. Director Common Stock 210,004 $97,274 $0.4632 31 Dec 2024 Direct
ZEVRA THERAPEUTICS, INC. CCO Stock Option (right to buy) 75,000 29 Jan 2026 Direct

Insider Reports Filed by Joshua Schafer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZVRA ZEVRA THERAPEUTICS, INC. 03 Feb 2026 1 -$96,500 4 CCO 04 Feb 2026, 16:27
ZVRA ZEVRA THERAPEUTICS, INC. 29 Jan 2026 7 -$29,800 4 CCO 02 Feb 2026, 17:19
ZVRA ZEVRA THERAPEUTICS, INC. 13 Feb 2025 1 -$82,527 4 CCO & EVP, Bus. Development 14 Feb 2025, 17:55
ZVRA ZEVRA THERAPEUTICS, INC. 30 Jan 2025 4 $0 4 CCO & EVP, Bus. Development 03 Feb 2025, 17:22
SHPH Shuttle Pharmaceuticals Holdings, Inc. 31 Dec 2024 1 $0 5/A Director 06 Feb 2025, 19:34
ZVRA ZEVRA THERAPEUTICS, INC. 31 Jan 2024 1 $0 4 CCO & EVP, Bus. Development 02 Feb 2024, 21:22
ZVRA ZEVRA THERAPEUTICS, INC. 05 Sep 2023 1 +$2,564 4 CCO & EVP, Bus. Development 06 Sep 2023, 17:11
ZVRA ZEVRA THERAPEUTICS, INC. 19 May 2023 1 +$5,416 4 CCO & EVP, Bus. Development 30 Jun 2023, 16:14
ZVRA ZEVRA THERAPEUTICS, INC. 14 Mar 2023 1 +$9,218 4 CCO & EVP, Bus. Development 15 Mar 2023, 20:14
ZVRA KEMPHARM, INC 09 Jan 2023 1 $0 4 CCO & EVP, Bus. Development 11 Jan 2023, 20:49
ZVRA KEMPHARM, INC 06 Jan 2023 0 $0 3 CCO & EVP, Bus. Development 10 Jan 2023, 20:17
SHPH Shuttle Pharmaceuticals Holdings, Inc. 29 Aug 2022 0 $0 3 Director 07 Sep 2022, 09:19